Proliferative Diabetic Retinopathy Market Share

Statistics for the 2023 & 2024 Proliferative Diabetic Retinopathy market share, created by Mordor Intelligence™ Industry Reports. Proliferative Diabetic Retinopathy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Proliferative Diabetic Retinopathy Industry

The Proliferative Diabetic Retinopathy Market is consolidated and consists of few major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Novartis AG, Regeneron Pharmaceuticals Inc, Allergan Plc, Hoffmann-La Roche (Genentech), Oxurion NV, Alimera Sciences, BCN Peptides, Glycadia Pharmaceuticals and Kowa Group.

Proliferative Diabetic Retinopathy Market Leaders

  1. Novartis AG

  2. Regeneron Pharmaceuticals Inc

  3. Allergan Plc

  4. Hoffmann-La Roche (Genentech)

  5. Oxurion NV

*Disclaimer: Major Players sorted in no particular order

Proliferative Diabetic Retinopathy landscape

Proliferative Diabetic Retinopathy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)